ME1036
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
ME1036, a novel parenteral carbapenem, was developed for the treatment of MRSA and vancomycin-intermediate S. aureus (VISA). A…
We have correlated the binding affinities of ME1036, a carbapenem, to the penicillin-binding proteins (PBPs) from Streptococcus…
1. Sahm D, Draghi D, Thornsberry C. Activity of ME1036, a novel anti-MRSA carbapenem, against Gram-positive and Gram-negative…
fer of such strains from animal to meat products, e.g. during slaughtering. The characterization and comparison of plasmids in…
ABSTRACT The efficacy of ME1036, a novel parenteral carbapenem, was compared with that of vancomycin by using a rabbit model of…
We investigated the antibacterial activities of 19 beta-lactams against three recombinant bacterial strains, in which three…
ME1036, formerly CP5609, is a novel parenteral carbapenem with a 7-acylated imidazo[5,1-b]thiazole-2-yl group directly attached…